Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Chronic Inflammatory Demyelinating Polyneuropathy
NCT00004772Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Sep 1992
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of Human normal immunoglobulin G in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by National Center for Research Resources. Started Sep 1992; status: completed.
02
Drugs
Human normal immunoglobulin G
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NCT00004772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004772.